Compare EVEX & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVEX | INMD |
|---|---|---|
| Founded | 2020 | 2008 |
| Country | United States | Israel |
| Employees | 198 | N/A |
| Industry | Aerospace | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 835.9M | 842.0M |
| IPO Year | N/A | 2018 |
| Metric | EVEX | INMD |
|---|---|---|
| Price | $2.83 | $13.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | $6.88 | ★ $17.33 |
| AVG Volume (30 Days) | ★ 1.2M | 716.6K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.74 |
| Revenue Next Year | $11,676.47 | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.34 | $12.72 |
| 52 Week High | $7.70 | $16.74 |
| Indicator | EVEX | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 45.78 | 49.24 |
| Support Level | $2.34 | $14.00 |
| Resistance Level | $3.18 | $14.70 |
| Average True Range (ATR) | 0.21 | 0.30 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 30.36 | 59.92 |
Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment, a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.